Sunshine Biopharma Stock Alpha and Beta Analysis
| SBFM Stock | USD 2.86 0.13 4.76% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Sunshine Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Sunshine Biopharma over a specified time horizon. Remember, high Sunshine Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Sunshine Biopharma's market risk premium analysis include:
Beta 1.01 | Alpha (0.16) | Risk 5.02 | Sharpe Ratio 0.0267 | Expected Return 0.13 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Sunshine |
Sunshine Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Sunshine Biopharma market risk premium is the additional return an investor will receive from holding Sunshine Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sunshine Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Sunshine Biopharma's performance over market.| α | -0.16 | β | 1.01 |
Sunshine Biopharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Sunshine Biopharma's Buy-and-hold return. Our buy-and-hold chart shows how Sunshine Biopharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Sunshine Biopharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Sunshine Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sunshine Biopharma shares will generate the highest return on investment. By understating and applying Sunshine Biopharma stock market price indicators, traders can identify Sunshine Biopharma position entry and exit signals to maximize returns.
Sunshine Biopharma Return and Market Media
The median price of Sunshine Biopharma for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2.89 with a coefficient of variation of 8.91. The daily time series for the period is distributed with a sample standard deviation of 0.25, arithmetic mean of 2.86, and mean deviation of 0.18. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Sunshine Biopharma Reports 2024 Third Quarter Results Year-To-Date Revenues Up 54 | 11/06/2024 |
2 | Disposition of tradable shares by Kiderchah Rabi of Sunshine Biopharma subject to Rule 16b-3 | 11/22/2024 |
About Sunshine Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Sunshine or other stocks. Alpha measures the amount that position in Sunshine Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 6.0K | 15.0K | 3.8K | 2.0K | Receivables Turnover | 29.29 | 2.27 | 9.44 | 8.97 |
Sunshine Biopharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Sunshine Biopharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sunshine Biopharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Sunshine Biopharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Sunshine Biopharma. Please utilize our Beneish M Score to check the likelihood of Sunshine Biopharma's management manipulating its earnings.
| 2nd of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Sunshine Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Sunshine Biopharma Backtesting, Sunshine Biopharma Valuation, Sunshine Biopharma Correlation, Sunshine Biopharma Hype Analysis, Sunshine Biopharma Volatility, Sunshine Biopharma History and analyze Sunshine Biopharma Performance. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Sunshine Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.